An efficacy trial of Omalizumab in patients with severe asthma and chronic rhinosinusitis complicated with eosinophilic otitis media

Trial Profile

An efficacy trial of Omalizumab in patients with severe asthma and chronic rhinosinusitis complicated with eosinophilic otitis media

Completed
Phase of Trial: Phase IV

Latest Information Update: 28 Jun 2016

At a glance

  • Drugs Omalizumab (Primary)
  • Indications Asthma; Otitis media; Rhinosinusitis
  • Focus Therapeutic Use
  • Most Recent Events

    • 28 Jun 2016 New trial record
    • 18 May 2016 Results presented at the 112th International Conference of the American Thoracic Society
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top